Oxford Square Capital to Announce Q4 2024 Earnings Soon
Oxford Square Capital Announces Upcoming Conference Call
Oxford Square Capital Corp. has scheduled an important conference call to review its fourth quarter 2024 earnings. This event is set for February 28, 2025, at 9:00 AM Eastern Time. Investors and stakeholders interested in participating can dial the toll-free number 1-800-549-8228.
Accessing the Recording
For those who cannot attend the live call, a recording will be available for 30 days post-event. To access this recording, simply call 1-888-660-6264 and use the replay passcode 06523#.
About Oxford Square Capital Corp.
Oxford Square Capital Corp. is recognized as a publicly-traded business development company focused primarily on investments in syndicated bank loans. Additionally, the company engages in debt and equity tranches of collateralized loan obligation (CLO) vehicles. These CLO investments may include warehouse facilities, providing essential financing structures to aggregate loans, laying the groundwork for CLO initiatives.
Stock Market Performance
The stock trading for Oxford Square Capital Corp. has remained stable recently, with the ticker symbol OXSQ representing its common shares on NASDAQ. Alongside OXSQ, two other instruments associated with the firm are OXSQG and OXSQZ, which denote its notes due in the coming years.
Details on Equity and Notes
Investors might be particularly interested in the current performance of the notes. For example, OXSQG, which corresponds to a 5.50% note due in 2028, is actively traded with its market fluctuating around $23.22. Another noteworthy note is OXSQZ, with a 6.25% maturity due in 2026, presently trading at $24.60.
Investor Engagement
The upcoming earnings call is an invaluable opportunity for analysts and investors to understand the strategic direction Oxford Square Capital is heading towards. The firm emphasizes transparency and communication with its stakeholders, ensuring they are informed about key events and performances.
Contact Information
For any inquiries related to this event, please reach out to Bruce Rubin at 203-983-5280. The firm remains poised to deliver insights and updates pertaining to its performance during the call.
Frequently Asked Questions
When is the conference call scheduled?
The conference call is scheduled for February 28, 2025, at 9:00 AM Eastern Time.
How can I access the call?
You can participate by calling the toll-free number 1-800-549-8228.
Will there be a recording available?
Yes, a recording will be available for 30 days after the call; call 1-888-660-6264 and use passcode 06523# to access it.
What is Oxford Square Capital's primary focus?
Oxford Square Capital focuses primarily on investments in syndicated bank loans and also engages in CLO debt and equity investments.
Who should I contact for more information?
You can contact Bruce Rubin at 203-983-5280 for more information.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
